Bibliografia UJ CM

1/4
Rodica Anghel, Alexander Bachmann, Meral Beksac, Thomas Brodowicz, Jindrich Finek, Radko Komadina, Krzysztof Krzemieniecki, Istvan Lang, Jozef Marencak, Roger von Moos, Martin Pecherstorfer, Tamara Rordorf, Damir Vrbanec, Christoph Zielinski.
Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease.
Wiener Klinische Wochenschrift
2013 : Vol. 125, nr 15-16, s. 439-447, il., bibliogr. 36 poz., sum.
p-ISSN: 0043-5325
AZ
ORG
AIF
IF: 0.791
Adres url:
Streszczenie w PubMed:
2/4
Antoaneta Tomova, Rupert Bartsch, Thomas Brodowicz, Valentina Tzekova, Constanta Timcheva, Christoph Wiltschke, Dany Abi Gerges, Janusz Pawlega, Stanislav Spanik, Moshe Inbar, Christoph C. Zielinski.
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients : a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG).
Breast Cancer Research and Treatment
2010 : Vol. 119, nr 1, s. 169-176, il., bibliogr. 28 poz., abstr.
p-ISSN: 0167-6806
AZ
ORG
AIF
IF: 5.785
3/4
Antoaneta Tomova, Thomas Brodowicz, Valentina Tzekova, Constantin Timcheva, Christoph Wiltschke, Dany Abi Gerges, Jan [Janusz] Pawlęga, Stanislav Spanik, Moshe Inbar, Christoph C. Zielinski.
Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine.
Journal of Clinical Oncology
2008 : Vol. 26, nr 15S, abstr. 1106
44th Annual Meeting of the American Society of Clinical Oncology, May 30-June 3, 2008, Chicago, IL, USA.
SZZ
SIF
4/4
Christoph Zielinski, Semir Beslija, Zrinka Mrsic-Krmpotic, Marzena Welnicka-Jaskiewicz, Christoph Wiltschke, Zsuzsanna Kahan, Mislav Grgic, Valentina Tzekova, Moshe Inbar, Jozika Cervek, Ivan Chernozemsky, Janos Szanto, Stanislav Spanik, Maria Wagnerova, Nicolae Ghilezan, Janusz Pawlega, Damir Vrbanec, Dmitry Khamtsov, Victoria Soldatenkova, Thomas Brodowicz.
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer : a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial.
Journal of Clinical Oncology
2005 : Vol. 23, nr 7, s. 1401-1408, il., bibliogr. 26 poz., abstr.
AZ
ORG
AIF
IF: 11.810
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ